Eva Tiensuu Janson

Hormone secretion predicts poor prognosis in lung neuroendocrine neoplasms

Lase, Ieva; Löfgren, Eir; Hegedus, Agnes; Grönberg, Malin et al.

Ingår i Endocrine-Related Cancer, 2026

• DOI för Hormone secretion predicts poor prognosis in lung neuroendocrine neoplasms
• Ladda ner fulltext (pdf) av Hormone secretion predicts poor prognosis in lung neuroendocrine neoplasms

Controversies in NEN: An ENETS position statement on the interchangeability of somatostatin receptor PET tracers

Deroose, Christophe M.; Ambrosini, Valentina; Hofland, Johanes; Kaltsas, Gregory et al.

Ingår i Journal of neuroendocrinology, 2026

• DOI för Controversies in NEN: An ENETS position statement on the interchangeability of somatostatin receptor PET tracers

Characteristics, management, and outcomes of patients with VIPoma-A retrospective analysis of the ENETS database

Bartsch, Detlef K.; Mais, L.; de Mestier, L.; Baudin, E. et al.

Ingår i Journal of neuroendocrinology, 2026

• DOI för Characteristics, management, and outcomes of patients with VIPoma-A retrospective analysis of the ENETS database
• Ladda ner fulltext (pdf) av Characteristics, management, and outcomes of patients with VIPoma-A retrospective analysis of the ENETS database

Phosphohistone H3 and Ki-67 as prognostic markers in metastatic small intestinal neuroendocrine tumours: A comparative, retrospective, cohort study

Papantoniou, Dimitrios; Grönberg, Malin; Tiensuu Janson, Eva

Ingår i Journal of neuroendocrinology, 2026

• DOI för Phosphohistone H3 and Ki-67 as prognostic markers in metastatic small intestinal neuroendocrine tumours: A comparative, retrospective, cohort study
• Ladda ner fulltext (pdf) av Phosphohistone H3 and Ki-67 as prognostic markers in metastatic small intestinal neuroendocrine tumours: A comparative, retrospective, cohort study

Surgical management of small intestinal neuroendocrine tumours

Hallet, Julie; Falconi, Massimo; Bennet, Sean; Frilling, Andrea et al.

Ingår i BJS, 2026

• DOI för Surgical management of small intestinal neuroendocrine tumours
• Ladda ner fulltext (pdf) av Surgical management of small intestinal neuroendocrine tumours

Hormone secretion predicts poor prognosis in lung neuroendocrine neoplasms

Lase, Ieva; Löfgren, Eir; Hegedus, Agnes; Grönberg, Malin et al.

Ingår i Endocrine-Related Cancer, 2026

• DOI för Hormone secretion predicts poor prognosis in lung neuroendocrine neoplasms
• Ladda ner fulltext (pdf) av Hormone secretion predicts poor prognosis in lung neuroendocrine neoplasms

Controversies in NEN: An ENETS position statement on the interchangeability of somatostatin receptor PET tracers

Deroose, Christophe M.; Ambrosini, Valentina; Hofland, Johanes; Kaltsas, Gregory et al.

Ingår i Journal of neuroendocrinology, 2026

• DOI för Controversies in NEN: An ENETS position statement on the interchangeability of somatostatin receptor PET tracers

Characteristics, management, and outcomes of patients with VIPoma-A retrospective analysis of the ENETS database

Bartsch, Detlef K.; Mais, L.; de Mestier, L.; Baudin, E. et al.

Ingår i Journal of neuroendocrinology, 2026

• DOI för Characteristics, management, and outcomes of patients with VIPoma-A retrospective analysis of the ENETS database
• Ladda ner fulltext (pdf) av Characteristics, management, and outcomes of patients with VIPoma-A retrospective analysis of the ENETS database

Phosphohistone H3 and Ki-67 as prognostic markers in metastatic small intestinal neuroendocrine tumours: A comparative, retrospective, cohort study

Papantoniou, Dimitrios; Grönberg, Malin; Tiensuu Janson, Eva

Ingår i Journal of neuroendocrinology, 2026

• DOI för Phosphohistone H3 and Ki-67 as prognostic markers in metastatic small intestinal neuroendocrine tumours: A comparative, retrospective, cohort study
• Ladda ner fulltext (pdf) av Phosphohistone H3 and Ki-67 as prognostic markers in metastatic small intestinal neuroendocrine tumours: A comparative, retrospective, cohort study

Surgical management of small intestinal neuroendocrine tumours

Hallet, Julie; Falconi, Massimo; Bennet, Sean; Frilling, Andrea et al.

Ingår i BJS, 2026

• DOI för Surgical management of small intestinal neuroendocrine tumours
• Ladda ner fulltext (pdf) av Surgical management of small intestinal neuroendocrine tumours

Controversies in neuroendocrine neoplasms: An European Neuroendocrine Tumor Society position statement on the role of surgery of the primary tumour in metastatic small intestinal and pancreatic neuroendocrine tumours

Partelli, Stefano; Bartsch, Detlef K.; Falconi, Massimo; Grossman, Ashley et al.

Ingår i Journal of neuroendocrinology, 2026

• DOI för Controversies in neuroendocrine neoplasms: An European Neuroendocrine Tumor Society position statement on the role of surgery of the primary tumour in metastatic small intestinal and pancreatic neuroendocrine tumours

Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline

Perez, Kimberly; Del Rivero, Jaydira; Kennedy, Erin B.; Basu, Sandip et al.

Ingår i JCO Oncology Practice, s. 19-35, 2026

• DOI för Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline
• Ladda ner fulltext (pdf) av Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline

Hypokalaemia and hypercortisolaemia at diagnosis are negative prognostic factors: a retrospective analysis of the medical management of ectopic Cushing syndrome

Lase, Ieva; Grönberg, Malin; Welin, Staffan; Tiensuu Janson, Eva

Ingår i ESMO Rare Cancers, 2025

• DOI för Hypokalaemia and hypercortisolaemia at diagnosis are negative prognostic factors: a retrospective analysis of the medical management of ectopic Cushing syndrome
• Ladda ner fulltext (pdf) av Hypokalaemia and hypercortisolaemia at diagnosis are negative prognostic factors: a retrospective analysis of the medical management of ectopic Cushing syndrome

Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients

Papantoniou, Dimitrios; Fröss-Baron, Katarzyna; Garske Roman, Ulrike; Sundin, Anders et al.

Ingår i Journal of neuroendocrinology, 2025

• DOI för Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients
• Ladda ner fulltext (pdf) av Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients

Multivariate survival analyses of 544 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC) given first-line chemotherapy (NORDIC NEC 2)

Sorbye, H.; Hjortland, G. O.; Vestermark, L. W.; Ladekarl, M. et al.

Ingår i Journal of neuroendocrinology, 2025

• DOI för Multivariate survival analyses of 544 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC) given first-line chemotherapy (NORDIC NEC 2)

Impact on symptoms and survival of bone metastases in patients with small-intestinal neuroendocrine tumours

Wedin, Maria; Tiensuu Janson, Eva; Wallin, Göran; Sundin, Anders et al.

Ingår i Journal of neuroendocrinology, 2025

• DOI för Impact on symptoms and survival of bone metastases in patients with small-intestinal neuroendocrine tumours
• Ladda ner fulltext (pdf) av Impact on symptoms and survival of bone metastases in patients with small-intestinal neuroendocrine tumours

Comparison of two prognostic models for the treatment of pancreatic NET with PRRT

Tiensuu Janson, Eva; Fröss-Baron, Katarzyna; Grönberg, Malin; Ziolkowska, B.

Ingår i Journal of neuroendocrinology, 2025

Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study

Sorbye, Halfdan; Hjortland, Geir Olav; Vestermark, Lene Weber; Ladekarl, Morten et al.

Ingår i British Journal of Cancer, s. 316-324, 2025

• DOI för Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study
• Ladda ner fulltext (pdf) av Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study

Prevalence of metastases outside the liver and abdominal lymph nodes on ⁶⁸Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours

Wedin, Maria; Tiensuu Janson, Eva; Wallin, Göran; Sundin, Anders et al.

Ingår i Journal of neuroendocrinology, 2024

• DOI för Prevalence of metastases outside the liver and abdominal lymph nodes on ⁶⁸Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours
• Ladda ner fulltext (pdf) av Prevalence of metastases outside the liver and abdominal lymph nodes on ⁶⁸Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours

European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well-differentiated small intestine neuroendocrine tumours

Lamarca, Angela; Bartsch, Detlef K.; Caplin, Martyn; Kos‐Kudla, Beata et al.

Ingår i Journal of neuroendocrinology, 2024

• DOI för European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well-differentiated small intestine neuroendocrine tumours

Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up5

Hadoux, J.; Lamarca, A.; Grande, E.; Deandreis, D. et al.

Ingår i ESMO Open, 2024

• DOI för Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up5
• Ladda ner fulltext (pdf) av Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up5

Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort

Papantoniou, Dimitrios; Grönberg, Malin; Thiis-Evensen, Espen; Sorbye, Halfdan et al.

Ingår i Endocrine-Related Cancer, 2023

• DOI för Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
• Ladda ner fulltext (pdf) av Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma

Sorbye, Halfdan; Grande, Enrique; Pavel, Marianne; Tesselaar, Margot et al.

Ingår i Journal of neuroendocrinology, 2023

• DOI för European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma
• Ladda ner fulltext (pdf) av European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma

Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.

Dam, Gitte; Grønbæk, Henning; Sundlöv, Anna; Botling, Johan et al.

Ingår i Acta Oncologica, s. 431-437, 2023

• DOI för Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.

Heterogeneity of Small Intestinal Neuroendocrine Tumors Metastasis: Biologic Patterns of a Series with Virchow's Node Involvement

Wedin, Maria; Tsoli, Marina; Wallin, Göran; Tiensuu Janson, Eva et al.

Ingår i Cancers, 2022

• DOI för Heterogeneity of Small Intestinal Neuroendocrine Tumors Metastasis: Biologic Patterns of a Series with Virchow's Node Involvement
• Ladda ner fulltext (pdf) av Heterogeneity of Small Intestinal Neuroendocrine Tumors Metastasis: Biologic Patterns of a Series with Virchow's Node Involvement

Loss of Y in leukocytes as a risk factor for critical COVID-19 in men

Bruhn-Olszewska, Bozena; Davies, Hanna; Sarkisyan, Daniil; Juhas, Ulana et al.

Ingår i Genome Medicine, 2022

• DOI för Loss of Y in leukocytes as a risk factor for critical COVID-19 in men
• Ladda ner fulltext (pdf) av Loss of Y in leukocytes as a risk factor for critical COVID-19 in men

Adrenalectomy in ectopic Cushing's syndrome: A retrospective cohort study from a tertiary care centre

Lase, Ieva; Grönberg, Malin; Norlén, Olov; Stålberg, Peter et al.

Ingår i Journal of neuroendocrinology, 2021

• DOI för Adrenalectomy in ectopic Cushing's syndrome: A retrospective cohort study from a tertiary care centre

Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2

Papantoniou, Dimitrios; Grönberg, Malin; Landerholm, Kalle; Welin, Staffan et al.

Ingår i Endocrine, s. 893-904, 2021

• DOI för Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2
• Ladda ner fulltext (pdf) av Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2

Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms

Pommergaard, Hans-Christian; Nielsen, Kirstine; Sorbye, Halfdan; Federspiel, Birgitte et al.

Ingår i Journal of neuroendocrinology, 2021

• DOI för Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms

A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations

Elvebakken, Hege; Perren, Aurel; Scoazec, Jean-Yves; Tang, Laura H. et al.

Ingår i Neuroendocrinology, s. 883-894, 2021

• DOI för A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations

Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Tiensuu Janson, Eva; Knigge, Ulrich; Dam, Gitte; Federspiel, Birgitte et al.

Ingår i Acta Oncologica, s. 931-941, 2021

• DOI för Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
• Ladda ner fulltext (pdf) av Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing's syndrome

Lase, Ieva; Strele, Ieva; Grönberg, Malin; Kozlovacki, Gordana et al.

Ingår i Hormones, s. 351-360, 2020

• DOI för Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing's syndrome
• Ladda ner fulltext (pdf) av Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing's syndrome

Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3

Ali, Abir Salwa; Perren, Aurel; Lindskog, Cecilia; Welin, Staffan et al.

Ingår i Scientific Reports, 2020

• DOI för Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3
• Ladda ner fulltext (pdf) av Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3

PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3

Ali, Abir Salwa; Langer, Seppo W.; Federspiel, Birgitte; Hjortland, Geir Olav et al.

Ingår i PLOS ONE, 2020

• DOI för PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
• Ladda ner fulltext (pdf) av PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3

Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors

Dam, Gitte; Gronbaek, Henning; Sorbye, Halfdan; Evensen, Espen Thiis et al.

Ingår i Neuroendocrinology, s. 217-224, 2020

• DOI för Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors

Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma

Georgantzi, Kleopatra; Tsolakis, Apostolos V.; Jakobson, Åke; Christofferson, Rolf et al.

Ingår i Endocrine pathology, s. 173-179, 2019

• DOI för Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma
• Ladda ner fulltext (pdf) av Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma

Diagnostic Ultrasound-Guided Cutting Needle Biopsies in Neuroblastoma: a safe and efficient procedure

Georgantzi, Kleopatra; Sköldenberg, Erik; Tiensuu Janson, Eva; Jakobson, Åke et al.

Ingår i Journal of Pediatric Surgery, s. 1253-1256, 2019

• DOI för Diagnostic Ultrasound-Guided Cutting Needle Biopsies in Neuroblastoma: a safe and efficient procedure

Unmet Needs in Appendiceal Neuroendocrine Neoplasms

Toumpanakis, Christos; Fazio, Nicola; Tiensuu Janson, Eva; Hörsch, Dieter et al.

Ingår i Neuroendocrinology, s. 37-44, 2019

• DOI för Unmet Needs in Appendiceal Neuroendocrine Neoplasms

Ghrelin expression is associated with a favorable outcome in male breast cancer

Grönberg, Malin; Nilsson, Cecilia; Markholm, Ida; Hedenfalk, Ingrid et al.

Ingår i Scientific Reports, 2018

• DOI för Ghrelin expression is associated with a favorable outcome in male breast cancer
• Ladda ner fulltext (pdf) av Ghrelin expression is associated with a favorable outcome in male breast cancer

Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)

Ali, Abir Salwa; Grönberg, Malin; Langer, Seppo W.; Ladekarl, Morten et al.

Ingår i Medical Oncology, 2018

• DOI för Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
• Ladda ner fulltext (pdf) av Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)

Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors.

Georgantzi, Kleopatra; Sköldenberg, Erik; Stridsberg, Mats; Kogner, Per et al.

Ingår i Pediatric Hematology & Oncology, s. 156-165, 2018

• DOI för Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors.
• Ladda ner fulltext (pdf) av Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors.

Intravenous versus Oral Etoposide: Efficacy and Correlation to Clinical Outcome in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)

Ali, Abir A.; Grönberg, Malin; Hjortland, G. O.; Grønbæk, H. et al.

Ingår i Neuroendocrinology, s. 184-184, 2018

• DOI för Intravenous versus Oral Etoposide: Efficacy and Correlation to Clinical Outcome in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)

A Prospective Nordic Study on the Use of Chromogranin A for the Prediction of Progression in Patients with Pancreatic and Small Intestinal Neuroendocrine Tumors

Dam, G.; Grønbæk, H.; Sørbye, H.; Thiis-Evensen, E. et al.

Ingår i Neuroendocrinology, s. 152-152, 2018

• DOI för A Prospective Nordic Study on the Use of Chromogranin A for the Prediction of Progression in Patients with Pancreatic and Small Intestinal Neuroendocrine Tumors

Association of a Prophylactic surgical approach to Stage IV Small Intestinal Neuroendocrine Tumors with Survival.

Daskalakis, Kosmas; Karakatsanis, Andreas; Hessman, Ola; Stuart, Heather C. et al.

Ingår i JAMA Oncology, s. 183-189, 2018

• DOI för Association of a Prophylactic surgical approach to Stage IV Small Intestinal Neuroendocrine Tumors with Survival.

Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma

Ali, Abir Salwa; Grönberg, Malin; Federspiel, Birgitte; Scoazec, Jean-Yves et al.

Ingår i PLOS ONE, 2017

• DOI för Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma
• Ladda ner fulltext (pdf) av Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma

Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer

Grönberg, Malin; Ahlin, Cecilia; Naeser, Ylva; Tiensuu Janson, Eva et al.

Ingår i PLOS ONE, 2017

• DOI för Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
• Ladda ner fulltext (pdf) av Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer

DcR3, TFF3 and Midkine are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors

Edfeldt, Katarina; Daskalakis, Kosmas; Bäcklin, Christofer; Norlén, Olov et al.

Ingår i Neuroendocrinology, s. 170-181, 2017

• DOI för DcR3, TFF3 and Midkine are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors

A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors

Dumanski, Jan P.; Rasi, Chiara; Björklund, Peyman; Davies, Hanna et al.

Ingår i Endocrine-Related Cancer, s. 427-443, 2017

• DOI för A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors
• Ladda ner fulltext (pdf) av A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors

Resection of Liver Metastases in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Carcinomas: A Nordic Multicenter Study

Galleberg, R. B.; Knigge, U.; Tiensuu Janson, Eva; Vestermark, L. W. et al.

Ingår i Neuroendocrinology, s. 264-264, 2017

Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas

Galleberg, R. B.; Knigge, U.; Tiensuu Janson, Eva; Vestermark, L. W. et al.

Ingår i European Journal of Surgical Oncology, s. 1682-1689, 2017

• DOI för Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues

Hicks, Rodney J.; Kwekkeboom, Dik J.; Krenning, Eric; Bodei, Lisa et al.

Ingår i Neuroendocrinology, s. 295-309, 2017

• DOI för ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors

Kaltsas, Gregory; Caplin, Martyn; Davies, Philippa; Ferone, Diego et al.

Ingår i Neuroendocrinology, s. 245-254, 2017

• DOI för ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors
• Ladda ner fulltext (pdf) av ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors

Expression of Mutated p53 Protein in Gastroenteropancreatic Neuroendocrine Carcinoma (WHO G3)

Ali, Abir; Grönberg, Malin; Federspiel, B.; Hjortland, G. O. et al.

Ingår i Neuroendocrinology, s. 43-43, 2016

Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours

Söderquist, Fanny; Tiensuu Janson, Eva; Rasmusson, Annica; Alit, Abir et al.

Ingår i PLOS ONE, 2016

• DOI för Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours
• Ladda ner fulltext (pdf) av Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours

Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study

Haugvik, Sven-Petter; Janson, Eva Tiensuu; Osterlund, Pia; Langer, Seppo W. et al.

Ingår i Annals of Surgical Oncology, s. 1721-1728, 2016

• DOI för Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study

Midkine Is a New Novel Serum Biomarker in Small Intestinal Neuroendocrine Tumors (SI-NETs)

Daskalakis, Kosmas; Edfeldt, Katarina; Norlén, Olov; Karakatsanis, Andreas et al.

Ingår i Neuroendocrinology, s. 45-45, 2016

Mutagenesis: smoking is associated with mosaic loss of chromosome Y

Dumanski, Jan P.; Rasi, Chiara; Lönn, Mikael; Davies, Hanna et al.

Ingår i Science, s. 81-83, 2015

• DOI för Mutagenesis: smoking is associated with mosaic loss of chromosome Y

Histidine decarboxylase and urinary methylimidazoleacetic acid in gastric neuroendocrine cells and tumours

Tsolakis, Apostolos V.; Grimelius, Lars; Granerus, Goran; Stridsberg, Mats et al.

Ingår i World Journal of Gastroenterology, s. 13240-13249, 2015

• DOI för Histidine decarboxylase and urinary methylimidazoleacetic acid in gastric neuroendocrine cells and tumours

Somatostatin receptor 1-5; expression profiles during rat development

Ludvigsen, Eva; Carlsson, Carina; Janson, Eva Tiensuu; Sandler, Stellan et al.

Ingår i Upsala Journal of Medical Sciences, s. 157-168, 2015

• DOI för Somatostatin receptor 1-5; expression profiles during rat development

Signatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancer

Forsberg, Lars A.; Rasi, Chiara; Pekar, Gyula; Davies, Hanna et al.

Ingår i Genome Research, s. 1521-1535, 2015

• DOI för Signatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancer
• Ladda ner fulltext (pdf) av Signatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancer

Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer

Forsberg, Lars A.; Rasi, Chiara; Malmqvist, Niklas; Davies, Hanna et al.

Ingår i Nature Genetics, s. 624-628, 2014

• DOI för Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer

TCEB3C a putative tumor suppressor gene of small intestine neuroendocrine tumors

Edfeldt, Katarina; Ahmad, Tanveer; Åkerström, Göran; Janson, Eva T et al.

Ingår i Endocrine-Related Cancer, s. 275-284, 2014

• DOI för TCEB3C a putative tumor suppressor gene of small intestine neuroendocrine tumors

Treatment with somatostatin analogues may delay progression of neuroendocrine tumours

Janson, Eva Tiensuu

Ingår i Acta Oncologica, s. 1283-1283, 2014

• DOI för Treatment with somatostatin analogues may delay progression of neuroendocrine tumours

Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study

Sorbye, H; Welin, Staffan; Langer, S.W.; Vestermark, L.W. et al.

Ingår i Annals of Oncology, s. 152-160, 2013

• DOI för Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study

Ghrelin and Obestatin in Human Neuroendocrine Tumors: Expression and Effect on Obestatin Levels after Food Intake

Grönberg, Malin; Tsolakis, Apostolos V; Holmbäck, Ulf; Stridsberg, Mats et al.

Ingår i Neuroendocrinology, s. 291-299, 2013

• DOI för Ghrelin and Obestatin in Human Neuroendocrine Tumors: Expression and Effect on Obestatin Levels after Food Intake
• Ladda ner fulltext (pdf) av Ghrelin and Obestatin in Human Neuroendocrine Tumors: Expression and Effect on Obestatin Levels after Food Intake

Ki-67 Proliferative Index Predicts Response to Chemotherapy and Survival in 252 Patients with High-Grade Gastrointestinal Neuroendocrine Carcinoma (WHO G3)

Sorbye, Halfdan; Welin, Staffan; Langer, Seppo; Vestermark, Lena et al.

Ingår i Pancreas, s. 382-382, 2013

TCEB3C (Elongin A3) on chromosome 18 presents a putative tumor suppressor gene of small intestine neuroendocrine tumors.

Edfeldt, Katarina; Ahmad, Tanvver; Åkerstrom, Göran; Janson, Eva Tiensuu et al.

Ingår i Cancer Research, 2013

• DOI för TCEB3C (Elongin A3) on chromosome 18 presents a putative tumor suppressor gene of small intestine neuroendocrine tumors.

Long-Term Results of Surgery for Small Intestinal Neuroendocrine Tumors at a Tertiary Referral Center

Norlén, Olov; Stålberg, Peter; Öberg, Kjell; Eriksson, John et al.

Ingår i World Journal of Surgery, s. 1419-1431, 2012

• DOI för Long-Term Results of Surgery for Small Intestinal Neuroendocrine Tumors at a Tertiary Referral Center

Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer

Grönberg, Malin; Fjällskog, Marie-Louise; Jirström, Karin; Tiensuu Janson, Eva

Ingår i Acta Oncologica, s. 386-393, 2012

• DOI för Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer

Somatostatin receptor expression in non-medullary thyroid carcinomas

Pazaitou-Panayiotou, Kalliopi; Tiensuu Janson, Eva; Koletsa, Triantafyllia; Kotoula, Vassiliki et al.

Ingår i Hormones, s. 290-296, 2012

Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors

Cunningham, Janet L.; Díaz de Ståhl, Teresita; Sjöblom, Tobias; Westin, Gunnar et al.

Ingår i Genes, Chromosomes and Cancer, s. 82-94, 2011

• DOI för Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors

Altered Expression of Somatostatin Receptors in Pancreatic Islets from NOD Mice Cultured at Different Glucose Concentrations In Vitro and in Islets Transplanted to Diabetic NOD Mice In Vivo

Ludvigsen, Eva; Stridsberg, Mats; Janson, Eva T.; Sandler, Stellan

Ingår i Experimental Diabetes Research, s. 623472, 2011

• DOI för Altered Expression of Somatostatin Receptors in Pancreatic Islets from NOD Mice Cultured at Different Glucose Concentrations In Vitro and in Islets Transplanted to Diabetic NOD Mice In Vivo

Differentiated expression of somatostatin receptor subtypes in experimental models and clinical neuroblastoma

Georgantzi, Kleopatra; Tsolakis, Apostolos V; Stridsberg, Mats; Jakobson, Åke et al.

Ingår i Pediatric Blood & Cancer, s. 584-589, 2011

• DOI för Differentiated expression of somatostatin receptor subtypes in experimental models and clinical neuroblastoma

A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum

Walsh, Kyle M.; Choi, Murim; Öberg, Kjell E.; Kulke, Matthew H. et al.

Ingår i Endocrine-Related Cancer, s. 171-180, 2011

• DOI för A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum

Five patients with malignant endocrine tumors treated with imatinib mesylate (Glivec®)

Kindmark, Henrik; Janson, Eva Tiensuu; Gustavsson, Bengt; Eriksson, Camilla et al.

Ingår i Acta Oncologica, s. 100-101, 2010

• DOI för Five patients with malignant endocrine tumors treated with imatinib mesylate (Glivec®)

Connective tissue growth factor expression in endocrine tumors is associated with high stromal expression of alpha-smooth muscle actin

Cunningham, Janet L.; Tsolakis, Apostolos V.; Jacobson, Annica; Janson, Eva Tiensuu

Ingår i European Journal of Endocrinology, s. 691-697, 2010

• DOI för Connective tissue growth factor expression in endocrine tumors is associated with high stromal expression of alpha-smooth muscle actin

Neuroendocrine markers are expressed in human mammary glands

Grönberg, Malin; Amini, Rose-Marie; Stridsberg, Mats; Janson, Eva Tiensuu et al.

Ingår i Regulatory Peptides, s. 68-74, 2010

• DOI för Neuroendocrine markers are expressed in human mammary glands

Chromogranin A is a Sensitive Marker for Detection of Recurrence in Neuroendocrine Tumors

Janson, Eva Tiensuu; Welin, Staffan; Eriksson, Barbro; Stridsberg, Mats

Ingår i Neuroendocrinology, s. 63-63, 2010

• DOI för Chromogranin A is a Sensitive Marker for Detection of Recurrence in Neuroendocrine Tumors

Obestatin/ghrelin cells in normal mucosa and endocrine tumours of the stomach

Tsolakis, Apostolos V.; Grimelius, Lars; Stridsberg, Mats; Falkmer, Sture E. et al.

Ingår i European Journal of Endocrinology, s. 941-949, 2009

• DOI för Obestatin/ghrelin cells in normal mucosa and endocrine tumours of the stomach

Elevated Plasma Chromogranin A is the First Indication of Recurrence in Radically Operated Midgut Carcinoid Tumours

Welin, Staffan; Stridsberg, Mats; Cunningham, Janet; Granberg, Dan et al.

Ingår i Neuroendocrinology, s. 302-307, 2009

• DOI för Elevated Plasma Chromogranin A is the First Indication of Recurrence in Radically Operated Midgut Carcinoid Tumours

Anemia in patients with midgut carcinoid, treated with alpha interferon: effects by erythropoietin treatment on the perceived quality of life

Larsson, Gunnel; Janson, Eva Tiensuu

Ingår i European Journal of Cancer Care, s. 200-204, 2008

• DOI för Anemia in patients with midgut carcinoid, treated with alpha interferon: effects by erythropoietin treatment on the perceived quality of life

Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands

Grönberg, Malin; Tsolakis, Apostolos; Magnusson, Linda; Janson, Eva Tiensuu et al.

Ingår i Journal of Histochemistry and Cytochemistry, s. 793-801, 2008

• DOI för Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands

Ghrelin Immunoreactive Cells in Gastric Endocrine Tumors and Their Relation to Plasma Ghrelin Concentration: Ghrelin in Gastric Endocrine Tumors

Tsolakis, Apostolos V.; Stridsberg, Mats; Grimelius, Lars; Portela-Gomes, Guida M. et al.

Ingår i Journal of Clinical Gastroenterology, s. 381-388, 2008

• DOI för Ghrelin Immunoreactive Cells in Gastric Endocrine Tumors and Their Relation to Plasma Ghrelin Concentration: Ghrelin in Gastric Endocrine Tumors

Endocrine Pancreatic Tumors: Diagnosis and Treatment

Tsolakis, Apostolos V; Janson, Eva Tiensuu

Ingår i Expert review of endocrinology & metabolism, s. 187-205, 2008

• DOI för Endocrine Pancreatic Tumors: Diagnosis and Treatment

Treatment with Combined Streptozotocin and Liposomal Doxorubicin in Metastatic Endocrine Pancreatic Tumors

Fjällskog, Marie-Louise H.; Janson, Eva Tiensuu; Falkmer, Ursula G.; Vatn, Morten H. et al.

Ingår i Neuroendocrinology, s. 53-8, 2008

• DOI för Treatment with Combined Streptozotocin and Liposomal Doxorubicin in Metastatic Endocrine Pancreatic Tumors

Tachykinins in endocrine tumors and the carcinoid syndrome

Cunningham, Janet L.; Janson, Eva Tiensuu; Agarwal, Smriti; Grimelius, Lars et al.

Ingår i European Journal of Endocrinology, s. 275-282, 2008

• DOI för Tachykinins in endocrine tumors and the carcinoid syndrome

Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours

Stridsberg, Mats; Eriksson, Barbro; Janson, Eva Tiensuu

Ingår i Regulatory Peptides, s. 95-98, 2008

• DOI för Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours

Differential expression of the five somatostatin receptor subtypes in human benign and malignant insulinomas: predominance of receptor subtype 4

Portela-Gomes, Guida Maria; Stridsberg, Mats; Grimelius, Lars; Rorstad, Otto et al.

Ingår i Endocrine pathology, s. 79-85, 2007

• DOI för Differential expression of the five somatostatin receptor subtypes in human benign and malignant insulinomas: predominance of receptor subtype 4

Liver embolization with trisacryl gelatin microspheres (embosphere) in patients with neuroendocrine tumors

Granberg, Dan; Eriksson, Lars-Gunnar; Welin, Staffan; Kindmark, Henrik et al.

Ingår i Acta Radiologica, s. 180-185, 2007

• DOI för Liver embolization with trisacryl gelatin microspheres (embosphere) in patients with neuroendocrine tumors

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors

Ekeblad, Sara; Sundin, Anders; Janson, Eva Tiensuu; Welin, Staffan et al.

Ingår i Clinical Cancer Research, s. 2986-2991, 2007

• DOI för Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors

Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years

Kindmark, Henrik; Sundin, Anders; Granberg, Dan; Dunder, Kristina et al.

Ingår i Medical Oncology, s. 330-337, 2007

• DOI för Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years

Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues

Ludvigsen, Eva; Stridsberg, Mats; Taylor, John; Culler, Michael et al.

Ingår i Regulatory Peptides, s. 1-9, 2007

• DOI för Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues

Malignant ileocaecal serotonin-producing carcinoid tumours: the presence of a solid growth pattern and/or Ki67 index above 1% identifies patients with a poorer prognosis

Cunningham, Janet Lynn; Grimelius, Lars; Sundin, Anders; Agarwal, Smriti et al.

Ingår i Acta Oncologica, s. 747-756, 2007

• DOI för Malignant ileocaecal serotonin-producing carcinoid tumours: the presence of a solid growth pattern and/or Ki67 index above 1% identifies patients with a poorer prognosis

Somatostatin induces rapid contraction of neuroendocrine cells

Saras, Jan; Grönberg, Malin; Stridsberg, Mats; Öberg, Kjell E. et al.

Ingår i FEBS Letters, s. 1957-1962, 2007

• DOI för Somatostatin induces rapid contraction of neuroendocrine cells

Upregulated expression of PDGF receptor beta in endocrine pancreatic tumors and metastases compared to normal endocrine pancreas

Fjällskog, Marie-Louise; Hessman, Ola; Eriksson, Barbro; Janson, Eva Tiensuu

Ingår i Acta Oncologica, s. 741-746, 2007

• DOI för Upregulated expression of PDGF receptor beta in endocrine pancreatic tumors and metastases compared to normal endocrine pancreas

Measurements of chromogranin B can serve as a complement to chromogranin A

Stridsberg, Mats; Eriksson, Barbro; Fellström, Bengt; Kristiansson, Gudjon et al.

Ingår i Regulatory Peptides, s. 80-83, 2007

• DOI för Measurements of chromogranin B can serve as a complement to chromogranin A

Lungcarcinoider: inte så benigna som man trott

Granberg, Dan; Eriksson, Barbro; Janson, Eva Tiensuu; Öberg, Kjell et al.

Ingår i Läkartidningen, s. 2382-2384, 2006

Expression of somatostatin receptor subtypes 1-5 in pancreatic islets of nomoglycemic and diabetic NOD mice

Ludvigsen, Eva; Stridsberg, Mats; Tiensuu Janson, Eva; Sandler, Stellan

Ingår i European Journal of Endocrinology, s. 445-454, 2005

• DOI för Expression of somatostatin receptor subtypes 1-5 in pancreatic islets of nomoglycemic and diabetic NOD mice

Treatment of endocrine pancreatic tumors

Fjällskog, Marie-Louise; Tiensuu Janson, Eva

Ingår i Acta Oncologica, s. 329-338, 2005

• DOI för Treatment of endocrine pancreatic tumors

Expression of somatostatin receptor subtypes 1 to 5 in pancreatic islets of normoglycaemic diabetic NOD mice

Ludvigsen, Eva; Stridsberg, Mats; Tiensuu Janson, Eva; Sandler, Stellan

Ingår i European Journal of Endocrinology, s. 445-454, 2005

A panel of 13 region-specific radioimmunoassays for measurements of human chromogranin B.

Stridsberg, Mats; Eriksson, Barbro; Oberg, Kjell; Tiensuu Janson, Eva

Ingår i Regul Pept, s. 193-9, 2005

High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours

Welin, Staffan; Janson, Eva Tiensuu; Sundin, Anders; Stridsberg, Mats et al.

Ingår i European Journal of Endocrinology, s. 107-112, 2004

• DOI för High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours

Subtype Selective Interactions of Somatostatin and Somatostatin Analogs with sst1, sst2, and sst5 in BON-1 Cells.

Ludvigsen, Eva; Stridsberg, Mats; Taylor, John E; Culler, Michael D et al.

Ingår i Med Oncol, s. 285-96, 2004

Expression and distribution of somatostatin receptor subtypes in the pancreatic islets of normal mice and rats

Ludvigsen, Eva; Olsson, R; Stridsberg, Mats; Tiensuu Janson, Eva et al.

Ingår i J Histochemistry and Cytochemistry, s. 391-400, 2004

A panel of 11 region-specific radioimmunoassays for measurements of human chromogranin A.

Stridsberg, Mats; Eriksson, Barbro; Oberg, Kjell; Tiensuu Janson, Eva

Ingår i Regul Pept, s. 219-27, 2004

Cellular localisation of chromogranins and processed products in the diffuse neuroendocrine system and related tumours

Stridsberg, Mats; Tiensuu Janson, Eva; Portela-Gomes, Guida M.

Ingår i Curr. Med. Chem., s. 149-160, 2004

Expression of somatostatin receptor subtypes 1 to 5 in tumor tissue and intratumoral vessels in malignant endocrine pancreatic tumors

Fjällskog, Marie-Louise; Ludvigsen, Eva; Stridsberg, Mats; Öberg, Kjell et al.

Ingår i Medical Oncology, s. 59-67, 2003

• DOI för Expression of somatostatin receptor subtypes 1 to 5 in tumor tissue and intratumoral vessels in malignant endocrine pancreatic tumors

Expression of molecular targets for tyrosine kinase receptor antagonistsin malignant endocrine pancreatic tumors

Fjallskog, Marie-Louise; Lejonklou, Margareta Halin; Öberg, Kjell E; Eriksson, BK et al.

Ingår i Clinical Cancer Research, s. 1469-1473, 2003

Octreoscan in patients with bronchial carcinoid tumours.

Granberg, Dan; Sundin, Anders; Tiensuu Janson, Eva; Oberg, Kjell et al.

Ingår i Clin Endocrinol (Oxf), s. 793-9, 2003

Expression of somatostatin receptor subtypes 1 to 5 in tumor tissue andintratumoral vessels in malignant endocrine pancreatic tumors.

Fjallskog, ML; Ludvigsen, E; Stridsberg, M; Oberg, K et al.

Ingår i Med Oncol, s. 59, 2003

A comparison between three commercial kits for chromogranin Ameasurements.

Stridsberg, M; Eriksson, B; Oberg, K; Tiensuu Janson, E

Ingår i J Endocrinol, s. 337, 2003

Neuroendocrine tumors--somatostatin receptor expression and somatostatin analog treatment.

Tiensuu Janson, E; Öberg, Kjell

Ingår i Cancer Chemother Biol Response Modif, s. 535-46, 2003

Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs.

Fjällskog, M L; Sundin, A; Westlin, J E; Öberg, K et al.

Ingår i Med Oncol, s. 35-42, 2002

Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases.

Hellman, P; Lundstrom, T; Ohrvall, U; Eriksson, B et al.

Ingår i World J Surg, s. 991, 2002

Levels of angiogenic peptides in sera from patients with carcinoid tumoursduring alpha-interferon treatment.

Nilsson, A; Tiensuu Janson, E; Eriksson, B; Larsson, A

Ingår i Anticancer Res., s. 4087, 2001

Treatment with cisplatin and etoposide in patients with neuroendocrinetumors.

Fjallskog, ML; Granberg, DP; Welin, SL; Eriksson, C et al.

Ingår i Cancer, s. 1101, 2001

Novel long-acting somatostatin analog with endocrine selectivity: potentsuppression of growth hormone but not of insulin.

Afargan, M; Tiensuu Janson, E; Gelerman, G; Rosenfeld, R et al.

Ingår i Endocrinology, s. 477, 2001

Transmembrane protein tyrosine phosphatase IA-2 (ICA512) is expressed inhuman midgut carcinoids but is not detectable in normal enterochromaffincells.

Cunningham, JL; Lopez-Egido, JR; Tiensuu Janson, E; Eriksson, B et al.

Ingår i J Endocrinol, s. 315, 2000

Expression of the five different somatostatin receptor subtypes in endocrine cells of the pancreas

Portela-Gomes, G M; Stridsberg, Mats; Grimelius, Lars; Oberg, Kjell et al.

Ingår i Appl. Immunohistochem., s. 126, 2000

Nuclear localization of 111In after intravenous injection of 111In-DTPA-D-Phe-1-octreotide to patients with neuroendocrine tumors.

Tiensuu Janson, E; Westlin, JE; Öhrvall, U; Öberg, K et al.

Ingår i J Nuclear Medicine, s. 1514, 2000

Tumour markers in neuroendocrine tumours

Oberg, Kjell; Tiensuu Janson, E; Eriksson, undefined

Ingår i Ital J Gastroenterol Hepatol, s. 160, 1999

In vivo cellular distribution and endocytosis of the somatostatin receptor-ligand complex

Lukinius, Agneta; Ohrvall, U; Westlin, Jan Eric; Oberg, Kjell et al.

Ingår i Acta Oncol., s. 383, 1999

The somatostatin analog octreotide inhibits growth of interleukin-6 (IL-dent and IL-6-independent human multiple myeloma cell lines.

Georgii-Hemming, P; Stromberg, T; Tiensuu Janson, E; Stridsberg, M et al.

Ingår i Blood, s. 1724, 1999

Somatostatin receptor ligands and their use in the treatment of endocrine disorders

Tiensuu Janson, E; Oberg, Kjell

Ingår i Curr Pharm Des, s. 693, 1999

Limited tumor involvement found at multiple endocrine neoplasia type I pancreatic exploration: can it be predicted by preoperative tumor localization?

Skogseid, Britt; Öberg, Kjell; Åkerström, Göran; Eriksson, Barbro et al.

Ingår i World Journal of Surgery, s. 673-677; discussion 667-668, 1998

• DOI för Limited tumor involvement found at multiple endocrine neoplasia type I pancreatic exploration: can it be predicted by preoperative tumor localization?

Determination of somatostatin receptor subtype 2 in carcinoid tumors by immunohistochemical investigation with somatostatin receptor subtype 2 antibodies.

Tiensuu Janson, E; Stridsberg, M; Gobl, A; Westlin, J E et al.

Ingår i Cancer Res, s. 2375-8, 1998

Expression of p68 protein kinase and its prognostic significance during IFN-a therapy in patients with carcinoid tumors

Zhou, Yinghua; Gobl, Anders; Wang, Shu; Jacobsen, M B et al.

Ingår i Eur J Cancer, s. 2046, 1998

Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center

Tiensuu Janson, Eva; Holmberg, Lars; Stridsberg, Mats; Eriksson, Barbro et al.

Ingår i Annals of Oncology, s. 685-690, 1997

• DOI för Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center

Induction of apoptosis in neuroendocrine tumors of digestive system during treatment with somatostatin analogs.

Imam, Hassan; Eriksson, Barbro; Lukinius, Agneta; Tiensuu Janson, Eva et al.

Ingår i Acta Oncol., s. 60714, 1997

The use of new somatostatin analogues, lanreotide and octastatin, inneuroendocrine gastro-intestinal tumours.

Eriksson, Barbro; Tiensuu Janson, E; Bax, ND; Mignon, M et al.

Ingår i Digestion, s. 77, 1996

A comparison between the efficacy of somatostatin receptor scintigraphy and in situ hybridization for somatostatin receptor subtype 2 mRNA to predict therapeutic outcome in carcinoid patients

Tiensuu Janson, E; Gobl, Anders; Kalkner, M; Oberg, Kjell

Ingår i Cancer Research, s. 2561, 1996

Induction of MxA-mRNA in patients with neuroendocrine tumors after interferon treatment - lack of correlation to antitumor response.

Imam, Hassan; Tiensuu Janson, Eva; Gobl, Anders; Alm, Gunnar et al.

Ingår i Anti-Cancer Research, s. 2191, 1995

Somatostatin receptor scintigraphy in patients with carcinoid tumors: Comparison between radioligand uptake and tumor markers.

Kalkner, Karl Mikael; Tiensuu Janson, Eva; Nilsson, S; Carlsson, S et al.

Ingår i Cancer Research, s. 5801, 1995

[111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment

Tiensuu Janson, Eva; Westlin, J E; Eriksson, B; Ahlström, Håkan et al.

Ingår i European Journal of Endocrinology, s. 577-581, 1994

• DOI för [111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment

Tropisetron (Navoban) in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience

Sorbe, Bengt; Andersson, Håkan; Schmidt, Margareta; Söderberg, Martin et al.

Ingår i Supportive Care in Cancer, s. 393-399, 1994

• DOI för Tropisetron (Navoban) in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience

Treatment with alpha-interferon versus alpha-interferon in combinationwith streptozocin and doxorubicin in patients with malignant carcinoidtumors: a randomized trial

Tiensuu Janson, Eva; Rönnblom, Lars; Ahlström, Håkan; Grander, D et al.

Ingår i Annals of Oncology, s. 635-638, 1992

Characterization of anti-interferon-alpha antibodies appearing duringrecombinant interferon-alpha 2a treatment.

Ronnblom, LE; Tiensuu Janson, E; Perers, A; Oberg, KE et al.

Ingår i Clin Exp Immunol, s. 330, 1992

Interferon-induced enhancement of 2',5'-oligoadenylate synthetase in mid-gut carcinoid tumours.

Grander, D; Oberg, K; Lundqvist, M L; Tiensuu Janson, E et al.

Ingår i Lancet, s. 337-40, 1990

[New medical therapy of neuroendocrine gastrointestinal tumors]

Eriksson, B; Janson, E T; Skogseid, B; Oberg, K

Ingår i Lakartidningen, s. 2668-72, 1990

Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Janson, Eva Tiensuu; Sorbye, Halfdan; Welin, Staffan; Federspiel, Birgitte et al.

Ingår i Acta Oncologica, s. 1284-1297, 2014

• DOI för Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

The biological hallmarks of ileal carcinoids

Cunningham, Janet L.; Janson, Eva T.

Ingår i European Journal of Clinical Investigation, s. 1353-1360, 2011

• DOI för The biological hallmarks of ileal carcinoids

Treatment of neuroendocrine tumors with somatostatin analogs

Janson, Eva Tiensuu

Ingår i Pituitary, s. 249-256, 2006

• DOI för Treatment of neuroendocrine tumors with somatostatin analogs

Somatostatin analogs in the treatment of neuroendocrine gastroenteropancreatic and intrathoracic tumors

Janson, Eva Tiensuu

Ingår i Journal of Endocrinological Investigation, s. 137-140, 2005

Tratamento dos tumores endócrinos do pâncreas.

Fjällskog, Marie-Louise; Janson, Eva Tiensuu

Ingår i Câncer Hoje- A Oncologia baseada em Evidência., s. 17-25, 2004

Carcinoid Tumors

Janson, Eva Tiensuu; Öberg, Kjell

Ingår i Hematology-oncology therapy, s. 72-79, McGraw-Hill, 2007

The carcinoid syndrome

Tiensuu Janson, E; Öberg, K

Ingår i Gastroenterology and Hepatology: the Modern Clinician's Guide, s. 823-830, Weinstein WM, Hawkey CJ and Bosch J, 2005

Diseases of the gut and liver: The carcinoid syndrome

Öberg, Kjell; Tiensuu Janson, Eva

Ingår i Clinical Gastroenterology and Hepatology, s. 823, Elsevier Mosby, 2005

Malignant neuroendocrine tumors.

Tiensuu Janson, E; Oberg, K

Ingår i Cancer Chemother Biol Response Modif, s. 463, 2002

Clinical GastroenterologyCarcinoid tumours.

Tiensuu Janson, E; Oberg, K

1996

Carcinoid tumours

Tiensuu Janson, E; Oberg, K

Ingår i Clinical Gastroenterology, 1996

Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors

Edfeldt, Katarina; Bäcklin, Christofer; Tiensuu Janson, Eva; Westin, Gunnar et al.

Neuroendocrine tumors-Somatostatin receptors and treatment

Tiensuu Janson, Eva; Öberg, Kjell

Ingår i Austral-Asian Journal of Cancer, s. 51-59, 2004